High resolution mass spectrometry for studying the interactions of cisplatin with oligonucleotides.
about
Tandem mass spectrometry for characterization of covalent adducts of DNA with anticancer therapeuticsComparative activities of nickel(II) and zinc(II) complexes of asymmetric [NN'O] ligands as 26S proteasome inhibitors.OMA and OPA--software-supported mass spectra analysis of native and modified nucleic acids.Structure-based DNA-targeting strategies with small molecule ligands for drug discovery.Understanding the interaction of an antitumoral platinum(II) 7-azaindolate complex with proteins and DNA.On the discovery, biological effects, and use of Cisplatin and metallocenes in anticancer chemotherapyProteins as possible targets for cytotoxic trans-platinum(II) complexes with aliphatic amine ligands: Further exceptions to the DNA paradigm.Analytical methodologies for metallomics studies of antitumor Pt-containing drugs.Anticancer metallodrug research analytically painting the "omics" picture--current developments and future trends.Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs.DNA or protein? Capillary zone electrophoresis-mass spectrometry rapidly elucidates metallodrug binding selectivity.Identification and discrimination of binding sites of an organoruthenium anticancer complex to single-stranded oligonucleotides by mass spectrometry.Novel heterobimetallic radiotheranostic: preparation, activity, and biodistribution.Studying the interactions of a platinum(II) 9-aminoacridine complex with proteins and oligonucleotides by ESI-TOF MS.Differentiation and distributions of DNA/cisplatin crosslinks by liquid chromatography-electrospray ionization-infrared multiphoton dissociation mass spectrometryComparison of MS/MS methods for characterization of DNA/cisplatin adducts.Deciphering of interactions between platinated DNA and HMGB1 by hydrogen/deuterium exchange mass spectrometry.Specific Interactions of Antitumor Metallocenes with Deoxydinucleoside Monophosphates.Sequence-dependent attack on peptides by photoactivated platinum anticancer complexes.
P2860
Q28486298-754EF3D6-A290-40AA-8AFD-DF06D896E250Q33884616-4B26662E-3633-4824-9845-E94E96CBB616Q34522151-AACE9EB6-78D9-462D-A05D-48E091710CE2Q34697484-6A1D3649-0312-493A-97E8-F402293431C4Q35222016-AEFA6AA1-7E71-40F1-B3E9-8566AD930190Q36107216-42BA2249-F34F-47C4-BB4B-FB25C2CCD7E2Q37576021-78E2DB96-F579-4AC1-B545-9E4D70665BFFQ37808951-7BEA3CDB-F75C-4915-B900-ED3103BD3D4FQ38052406-E30A5E03-E055-4191-86FB-4EF4E1D16EB3Q38105454-62ED81A0-A68A-455C-929D-B971AB263EC2Q38287806-B36BE3D7-AACF-411C-991E-EB92DD3C8D4BQ38305756-09B1A825-5891-4776-A100-60D5EDD15F2CQ39031995-7ECF45CF-AB5B-4C42-8E20-5D2E10BC0AF2Q39442095-FB376FC3-36CF-4FA8-A395-0831DF332957Q41850365-8C2B856A-7B8F-4BE0-9086-0CA4AFDA883FQ43249053-63C6206A-ADA3-4A89-9CA5-12BB4F02C7A2Q51045898-0870B9AB-8E42-486A-A80D-AF3304AE91E0Q53295821-6FCDFA57-B804-4861-A30E-2AE74C4E5711Q55322316-6BCCAFB4-61F1-4082-BF56-65DC48BFFA57
P2860
High resolution mass spectrometry for studying the interactions of cisplatin with oligonucleotides.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
High resolution mass spectrome ...... splatin with oligonucleotides.
@en
type
label
High resolution mass spectrome ...... splatin with oligonucleotides.
@en
prefLabel
High resolution mass spectrome ...... splatin with oligonucleotides.
@en
P50
P356
P1433
P1476
High resolution mass spectrome ...... splatin with oligonucleotides.
@en
P2093
Alexander E Egger
P304
10626-10633
P356
10.1021/IC801371R
P407
P577
2008-10-24T00:00:00Z